HomeCompareLDXHF vs PM

LDXHF vs PM: Dividend Comparison 2026

LDXHF yields 1238.39% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LDXHF wins by $124493861.49M in total portfolio value
10 years
LDXHF
LDXHF
● Live price
1238.39%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$124493861.54M
Annual income
$107,429,031,462,338.22
Full LDXHF calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — LDXHF vs PM

📍 LDXHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLDXHFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LDXHF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LDXHF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LDXHF
Annual income on $10K today (after 15% tax)
$105,263.16/yr
After 10yr DRIP, annual income (after tax)
$91,314,676,742,987.48/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, LDXHF beats the other by $91,314,676,740,869.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LDXHF + PM for your $10,000?

LDXHF: 50%PM: 50%
100% PM50/50100% LDXHF
Portfolio after 10yr
$62246930.79M
Annual income
$53,714,515,732,415.12/yr
Blended yield
86.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

LDXHF
No analyst data
Altman Z
-3.3
Piotroski
3/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LDXHF buys
0
PM buys
0
No recent congressional trades found for LDXHF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLDXHFPM
Forward yield1238.39%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$124493861.54M$49.6K
Annual income after 10y$107,429,031,462,338.22$2,492.02
Total dividends collected$123225412.32M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LDXHF vs PM ($10,000, DRIP)

YearLDXHF PortfolioLDXHF Income/yrPM PortfolioPM Income/yrGap
1← crossover$134,539$123,839.01$11,648$408.29+$122.9KLDXHF
2$1,701,076$1,557,119.40$13,589$495.90+$1.69MLDXHF
3$20,219,975$18,399,823.95$15,877$603.21+$20.20MLDXHF
4$226,038,135$204,402,761.69$18,580$734.88+$226.02MLDXHF
5$2,377,382,925$2,135,522,120.49$21,781$896.75+$2377.36MLDXHF
6$23,535,021,639$20,991,221,908.63$25,578$1,096.12+$23535.00MLDXHF
7$219,391,496,761$194,209,023,607.94$30,092$1,342.17+$219391.47MLDXHF
8$1,926,711,724,815$1,691,962,823,279.82$35,470$1,646.46+$1926711.69MLDXHF
9$15,948,439,325,295$13,886,857,779,743.26$41,892$2,023.58+$15948439.28MLDXHF
10$124,493,861,540,404$107,429,031,462,338.22$49,578$2,492.02+$124493861.49MLDXHF

LDXHF vs PM: Complete Analysis 2026

LDXHFStock

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Full LDXHF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this LDXHF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LDXHF vs SCHDLDXHF vs JEPILDXHF vs OLDXHF vs KOLDXHF vs MAINLDXHF vs MOLDXHF vs BTILDXHF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.